JLJincheng Liu

Jincheng Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jincheng Liu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    G Protein–Coupled Estrogen Receptor 30 Reduces Transverse Aortic Constriction–Induced Myocardial Fibrosis in Aged Female Mice by Inhibiting the ERK1/2 -MMP-9 Signaling Pathway

    by Xiaowu Wang, Jipeng Ma, Shuaishuai Zhang, Zilin Li, Ziwei Hong, Liqing Jiang, Weixun Duan, Jincheng Liu

    The incidence of cardiovascular diseases was significantly increased in postmenopausal women. The protection of estrogen in the cardiovascular system has been further reported for decades. Although menopausal hormone therapy has been used in many clinical trials, the debatable results indicate that the studies for elucidating the precise molecular mechanism are urgently required. G protein–coupled estrogen receptor 30 (GPR30) is a membrane receptor of estrogen and displays protective roles in diverse cardiovascular diseases. Previous studies have revealed that ERK1/2-mediated MMP-9 signaling was involved in ischemic heart diseases. However, the role of ERK1/2-mediated MMP-9 signaling in the protection of GPR30 against cardiac hypertrophy in aged female mice has not been investigated. Our present study demonstrated that GPR30 overexpression and its agonist G1 co-administration reduced transverse aortic constriction–induced myocardial fibrosis and preserved cardiac function in aged female mice. MMP-9 expression was markedly increased via ERK1/2 phosphorylation in transverse aortic constriction–injured myocardium of aged female mice. Further results showed that GPR30/G1 activation decreased MMP-9 expression via ERK1/2 inhibition, which further reduced TGF-β1 expression. Inhibition of the ERK1/2 signaling pathway by its inhibitor PD98059 suppressed the induction of the cardiomyocyte MMP-9 level caused by the GRP30 antagonist G15 and inhibited TGF-β1 expression in cardiac fibroblast in vitro. In summary, our results from in vivo and in vitro studies indicated that GPR30 activation inhibited myocardial fibrosis and preserved cardiac function via inhibiting ERK-mediated MMP-9 expression. Thus, the present study may provide the novel drug targets for prevention and treatment of cardiac pathological hypertrophy in postmenopausal women.


  • Open Access

    circ_0023461 Silencing Protects Cardiomyocytes from Hypoxia‐Induced Dysfunction through Targeting miR‐370‐3p/PDE4D Signaling

    by Kai Ren, Buying Li, Liqing Jiang, Zhiheng Liu, Fan Wu, Yi Zhang, Jincheng Liu, Weixun Duan

    Background. Acute myocardial infarction (AMI) is a common cardiovascular disease with high disability and mortality. Circular RNAs (circRNAs) are implicated in the pathomechanism of multiple human diseases, including AMI. This study intended to explore the function and working mechanism of a novel circRNA circ_0023461 in hypoxia‐induced cardiomyocytes. Methods. Reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) and Western blot assay were implemented to detect RNA and protein expression. Cell counting kit‐8 (CCK8) assay and 5‐ethynyl‐2 ′‐deoxyuridine (Edu) assay were conducted to analyze cell viability and proliferation ability. Cell migration and apoptosis were assessed by Transwell assay and flow cytometry. Cell oxidative stress was analyzed using the commercial kits. Enzyme‐linked immunosorbent assay (ELISA) was conducted to analyze cell inflammation. Cell glycolytic metabolism was evaluated using the commercial kits. Dual‐luciferase reporter assay and RNA pull‐down assay were conducted to verify the intermolecular interactions. Results. circ_0023461 expression was upregulated in AMI patients and hypoxia‐induced AC16 cells. Hypoxia restrained the viability, proliferation, migration, and glycolysis and induced the apoptosis, oxidative stress, and inflammation of AC16 cells, and these effects were attenuated by the silence of circ_0023461. MicroRNA‐370‐3p (miR‐370‐3p) was verified as a target of circ_0023461, and circ_0023461 silencing‐mediated protective effects in hypoxia‐induced cardiomyocytes were partly alleviated by the knockdown of miR‐370‐3p. miR‐370‐3p interacted with the 3 ′ untranslated region (3 ′ UTR) of phosphodiesterase 4D (PDE4D), and PDE4D overexpression partly reversed miR‐370‐3p overexpression‐induced protective effects in hypoxia‐induced cardiomyocytes. circ_0023461 can upregulate PDE4D expression by acting as a molecular sponge for miR‐370‐3p in AC16 cells. Conclusion. circ_0023461 knockdown attenuated hypoxia‐induced dysfunction in AC16 cells partly by targeting the miR‐370‐3p/PDE4D axis.


  • 3D Printing of Congenital and Prenatal Heart Diseases

    by Jian Yang, Xiangbin Pan, Wenzhi Pan, Meng Yang, Jincheng Liu, Jiayou Tang